Results 221 to 230 of about 58,715 (237)

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Lancet, The, 2007
Thierry Facon, Michel M Attal, Ibrahim Yakoub Agha   +2 more
exaly  

Thalidomide

Reactions Weekly, 2009
openaire   +1 more source

Thalidomide

Reactions Weekly, 2021
openaire   +1 more source

Identification of a Primary Target of Thalidomide Teratogenicity

Science, 2010
Takumi Ito, Yuki Yamaguchi, Hiroshi Handa   +2 more
exaly  

Thalidomide

Reactions Weekly, 2003
openaire   +2 more sources

Thalidomide

Reactions Weekly, 2017
openaire   +2 more sources

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Lancet, The, 2019
Phillipe Moreau, Michel M Attal, Bertrand Arnulf   +2 more
exaly  

Is thalidomide combination a new option for myeloma?

Nature Reviews Clinical Oncology, 2010
Antonio Palumbo
exaly  

Thalidomide

Reactions Weekly, 2019
openaire   +2 more sources

Thalidomide in Crohn's disease

Lancet, The, 1997
exaly